Katarzyna Piwocka

Has grant

Professor of the Nencki Institute of Experimental Biology, Polsh Academy of Sciences

Nencki Institute of Experimental Biology

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Verification of personalized therapeutic strategy based on Integrated Stress Response inhibition for myeloid neoplasms with PTPN11 mutations

Open Date: 2022-04-01

Close Date: 2026-03-01

Grant: Close

Cell adhesion molecules as regulators of tunneling nanotubes (TNTs) formation and protein transfer in leukemia microenvironment; role in therapy resistance

Open Date: 2020-10-01

Close Date: 2024-09-01

Grant: Close

Tunneling nanotubes (TNTs) within the leukemia microenvironment; influence of metabolic remodeling and implications for therapy

Open Date: 2019-03-01

Close Date: 2022-03-01

Grant: Close

FlowPROSPER - Flow cytometry Protein Signature platform for Personalized therapies

Open Date: 2018-05-01

Close Date: 2021-07-01

Grant: Close

Bio4Med – Biology for Medicine; International Doctoral Programme in Biological Bases of Human Diseases; PI of the project: “Precision medicine-guided synthetic lethality to eradicate quiescent and proliferating leukemia stem cells: molecular mechanisms and therapeutic applications”

Open Date: 2015-01-01

Close Date: 2020-04-01

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (20)

Laura Turos-Korgul

Nencki Institute of Experimental Biology, Polish Academy of Sciences

POLAND

Katarzyna Piwocka

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy

Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality

4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells.

Multi-omics analyses of early liver injury reveals cell-type-specific transcriptional and epigenomic shift

Comparison of Differentiation Pattern and WNT/SHH Signaling in Pluripotent Stem Cells Cultured under Different Conditions

Transcriptome profile of the sinoatrial ring reveals conserved and novel genetic programs of the zebrafish pacemaker

TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors

Genomic and physiological analyses of the zebrafish atrioventricular canal reveal molecular building blocks of the secondary pacemaker region

The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion

IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen

Collaborators (20)

Laura Turos-Korgul

Dr. Rashid Minhas

Patryk Gorniak

Michal Pawlak

Ksenia Matlawska-Wasowska

Italo Tempera

Shamba S. Mondal

Julian Swatler

Emilia Białopiotrowicz-Data

Przemysław Juszczyński

Daria Zdżalik-Bielecka

Karolina Archacka

Sławomir Lewicki

Karolina Matiakowska-Bryk

Maria A. Ciemerych

Dominik Cysewski

Urszula Wojda

Marta Miaczynska

Katarzyna Borg

Agata Kominek

Make your next move.